<DOC>
	<DOCNO>NCT02201303</DOCNO>
	<brief_summary>This study determine danirixin ( GSK1325756 ) concentration require inhibit neutrophil activation blood obtain Respiratory Syncytial Virus ( RSV ) -infected child &lt; 2 year healthy adult . The study evaluate difference neutrophil activation RSV-infected child &lt; 2 year healthy adult escalate concentration Chemokine ( C-X-C motif ) Ligand 1 ( CXCL1 ) danirixin determine RSV-infected child adult neutrophil similarly activate CXCL1 inhibit danirixin . This study guide dose prediction inhibit specific percentage neutrophils future pediatric RSV-infection study . This single-center , vitro study consist 2 part . Approximately 24 subject enrol , include 12 healthy adult 12 RSV-infected child &lt; 2 year .</brief_summary>
	<brief_title>Evaluation Danirixin ( GSK1325756 ) Inhibition CD11b Cell Surface Expression</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Respiratory Syncytial Virus Infections</mesh_term>
	<criteria>Healthy Adults Male/females age 18 64 year age inclusive , time signing informed consent Healthy determine responsible experienced physician , base medical evaluation include medical history physical examination . A subject clinical abnormality parameter ( ) specifically list inclusion exclusion criterion , may include Investigator consultation GSK Medical Monitor agree document find unlikely introduce additional risk factor interfere study procedure . Body weight &gt; = 45 kilogram ( kg ) body mass index ( BMI ) within range 18.532 kg/meter^2 ( inclusive ) . A female subject eligible participate know pregnant history deliver within past 3 month . Capable give write informed consent , include compliance requirement restriction list consent form . RSV Infected Children Male/females age &lt; 2 year , time parent ( ) /legal guardian ( ) signing informed consent . Healthy , except current RSVinfection , determine responsible experienced physician , base medical evaluation include medical history physical examination . A subject clinical abnormality parameter ( ) specifically list inclusion exclusion criterion , may include Investigator consultation GSK Medical Monitor agree document find unlikely introduce additional risk factor interfere study procedure . Body weight &gt; = 3.5 kg Documented RSVinfection , either RSVantigen RSVPCR RSVinfection clinical symptom onset within 5 day blood draw base parent ( ) /guardian ( ) history . Parent ( ) /legal guardian ( ) child capable give write informed consent , include compliance requirement restriction list consent form . Healthy Adults Any clinical infection within past 14 day per subject 's history . Acute chronic infectious/inflammatory disease history , include limited , hepatitis B , hepatitis C , human immuno virus ( HIV ) , inflammatory bowel disease , liver / biliary disease , pancreatitis , arthritis . Receiving systemic antiinflammatory immune modulate medication , include limited , nonsteroidal antiinflammatory ( NSAIDS ) glucocorticoid , within past 14 day . All medication permit . Any alcoholic beverage within 24 hour blood collection history regular alcohol consumption within 6 month study define : average weekly intake &gt; 14 drink male &gt; 7 drink female . One drink equivalent 12 gram ( g ) alcohol : 12 ounce ( 360 mL ) beer , 5 ounce ( 150 mL ) wine 1.5 ounce ( 45 mL ) 80 proof distil spirit . Current smoke history regular use tobacco nicotinecontaining product within 6 month prior screen . Strenuous exercise within 48 hour prior blood collection . Where participation study would result donation blood blood product excess 500 mL within 56 day period . The subject participate clinical trial receive investigational product within following time period prior sign inform consent current study : 30 day , 5 halflives twice duration biological effect investigational product ( whichever longer ) . RSV Infected Children A Child Care : A child place control protection agency , organization , institution entity court , government government body , act accordance power confer law regulation . A child care include child cared foster parent live care home institution , provide arrangement fall within definition . A child care include child adopt appointed legal guardian . Any clinical infection , besides current RSV infection , within past 14 day per subject 's history Acute chronic infectious/inflammatory disease history , include limited , hepatitis B , hepatitis C , HIV , liver / biliary disease , pancreatitis Receiving systemic antiinflammatory immune modulate medication , include limited , NSAIDS glucocorticoid , within past 14 day . All medication permit . Past medical history include prematurity &lt; 37 week , congenital heart disease , chronic lung disease , immunodeficiency . Where participation study would result withdrawal blood blood product excess 2 mL/kg 24 hour study period . The subject participate clinical trial receive investigational product within following time period prior parent ( ) /guardian ( ) signing inform consent current study : 30 day , 5 halflives twice duration biological effect investigational product ( whichever longer ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>CD11b</keyword>
	<keyword>Children</keyword>
	<keyword>Neutrophils</keyword>
	<keyword>Respiratory Syncytial Virus</keyword>
	<keyword>CXCR2</keyword>
	<keyword>CXCL1</keyword>
	<keyword>Danirixin</keyword>
</DOC>